Wie können wir helfen?
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
You do not have access to this post.
1445534
{:I53MJH2E}
1
https://www.zotero.org/styles/urban-research-and-practice?source=1
50
default
1
1
122
http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/